Kansuiphorin C and Kansuinin A ameliorate malignant ascites by modulating gut microbiota and related metabolic functions
Yi Zhang(Tianjin Medical University General Hospital), Li Zhang(Zhejiang Sci-Tech University), Jianwei Lou(Nanjing University of Chinese Medicine), Shi-Kang Zhou(Nanjing University of Chinese Medicine), Beihua Bao(Nanjing University of Chinese Medicine), Qiao Zhang(Changchun University of Chinese Medicine), Kang An(Nanjing University of Chinese Medicine), Yudan Cao(Nanjing University of Chinese Medicine), Weifeng Yao(Nanjing University of Chinese Medicine), Yuping Tang(Shaanxi University of Chinese Medicine)
Cited by 18
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k